Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.5468
+0.0306 (5.93%)
At close: Nov 6, 2026, 4:00 PM EST
0.5501
+0.0033 (0.60%)
Pre-market: Nov 9, 2026, 8:24 AM EST
RANI Revenue
Rani Therapeutics Holdings had revenue of $1.71M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $4.88M, up 306.42% year-over-year. In the year 2025, Rani Therapeutics Holdings had annual revenue of $1.63M with 58.85% growth. That makes Rani Therapeutics Holdings the 40,095th largest company in the world by revenue and 5,322nd in the United States.
Revenue (ttm)
$4.88M
Revenue Growth
+306.42%
P/S Ratio
15.63
Revenue / Employee
$68,690
Employees
71
Market Cap
76.22M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.63M | 605.00K | 58.85% |
| Dec 31, 2024 | 1.03M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 2.72M | 2.26M | 488.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 63.82M |
| Tonix Pharmaceuticals Holding | 29.10M |
| Coya Therapeutics | 8.02M |
| Atara Biotherapeutics | 6.19M |
| NeurAxis | 5.32M |
| MediciNova | 920.48K |
| Rallybio | 434.00K |
RANI News
- 19 days ago - Rani Therapeutics Holdings Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 26 days ago - Rani Therapeutics to Participate in the Chardan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Rani reports RaniPill acceptance into FDA Emerging Technology Program - TheFly
- 5 weeks ago - Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP) - GlobeNewsWire
- 7 weeks ago - Rani Therapeutics Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 2 months ago - Rani Therapeutics to Participate in Upcoming September Conferences - GlobeNewsWire
- 2 months ago - Rani Therapeutics initiated with a Buy at Chardan - TheFly
- 2 months ago - Rani Therapeutics reports Q2 EPS (4c), consensus (5c) - TheFly